Introducing SmartHeart®, the first fully integrated, portable, 12-lead ECG technology with unlimited 24/7 preliminary reads by SHL clinical staff – for faster, easier and better diagnosis of heart disease.
Using cutting-edge technology, SmartHeart delivers a high-quality 12-lead ECG with zero professional training or certification required – streamlining heart care for both clinicians and patients. Lightweight and completely portable, SmartHeart is capable of generating quick results in ~30 seconds.
SmartHeart’s fully integrated system eliminates the need for shaving, sticky adhesives or gels. Simply strap the device to the patient’s chest for a quick read on symptoms.
The device delivers an ECG in ~30 seconds with expert interpretations in about 30 minutes. Our HIPAA-compliant data handling process means that patient data is always secure and encrypted.
The in-app guided electrode application ensures a high-quality, accurate ECG is captured every time. When prescribed by a physician, patients can easily perform a full 12-lead ECG on their own.
Using the latest Bluetooth® technology, SmartHeart can pair wirelessly with any smart device to deliver fast and accurate results. Compatible with Apple and Android.
Our network of licensed, credentialed, and board-certified cardiologists are available around-the-clock to provide full ECG interpretations. Unlimited preliminary reads provided by SHL’s global telemedicine center.
SmartHeart® is the world’s most advanced portable 12-lead EKG system.
Lightweight, wireless, and FDA-cleared, it’s built for modern practices that want to deliver fast, accurate, and accessible cardiac care—anytime, anywhere.
Cardiac Events Can’t Wait—And Neither Should EKG Results
In today’s fast-paced healthcare environment, timely and accurate EKGs are essential—but traditional systems are bulky, slow, and often inaccessible outside hospitals.
Common challenges faced by professionals:
Proven in the Field. Backed by Data. Trusted by Clinicians.
Groundbreaking research from Imperial College London shows SmartHeart's potential to reshape cardiac care—especially post-acute coronary syndrome (ACS) monitoring.
Clinical Outcomes (TELE-ACS Study Highlights):
- 74% reduction in hospital readmissions compared to standard care
- 41% fewer emergency department visits
- Statistically significant results (p<0.001 for readmissions, p<0.002 for ED visits)
- Published in Journal of the American College of Cardiology (JACC), 2024
“Remote monitoring with SmartHeart® led to substantially better outcomes for patients recovering from cardiac events.”
— TELE-ACS Study, Imperial College London
Not at all. The system is intuitive and app-guided—designed for both medical and non-medical users.
Preliminary EKG reviews may be provided by SmartHeart’s Global Telemedicine Center, located outside the United States. With over 1 million EKGs reviewed, the center brings deep clinical experience to every reading. All data is handled in full compliance with HIPAA and U.S. privacy regulations. For full interpretations, SmartHeart offers on-demand reviews by licensed, credentialed, U.S.-based cardiologists, available 24/7 to support your clinical decision-making.
Yes! The physician portal allows you to overlay and compare ECGs to see changes over time—digitally and easily.
Yes! Our REST API allows for easy integration with your electronic health record system.
Yes. You can securely download or send encrypted links to colleagues using the SmartHeart platform.
SmartHeart is FDA-cleared for clinical use in the U.S., meaning it has met the FDA’s safety and effectiveness standards for medical devices.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.